[Antiblastic agent-induced vomiting: possibilities of its prevention and alizapride therapy]. / Vomito indotto da antiblastici: possibilità di prevenzione e terapia con alizapride.
Minerva Med
; 80(4): 389-92, 1989 Apr.
Article
en It
| MEDLINE
| ID: mdl-2725942
The spread of cytostatics has made the search for safe drugs for the prevention and treatment of induced vomiting important. In the present study, the protective (prophylactic and therapeutic) effect of Alizapride has been examined. Ten oncological patients of average age 60 were treated with a total of 30 cycles according to the commonest protocols of drugs with varying emetic potential (from bland bleomycin type to high cisplatin type). The patients were subdivided into two groups: a) prophylaxis before and after chemotherapy; b) treatment only as needed. Analysis of the data showed excellent tolerance and significant effectiveness in both groups.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Pirrolidinas
/
Vómitos
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Antieméticos
Tipo de estudio:
Guideline
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
It
Revista:
Minerva Med
Año:
1989
Tipo del documento:
Article
Pais de publicación:
Italia